1. NEWS: Report calls for a fully funded Global Fund and a focus on the leadership of networks of key populations
A new report released by the Global Fund Advocates Network and the Free Space Process partnership says the Global Fund is uniquely placed to maximize investments in key and vulnerable populations.
2. NEWS: End-2015 results released
Programs supported by The Global Fund added another 641,000 people on antiretroviral treatment in the last half of 2015, bringing cumulative results to 9.2 million. During that same period, the number of smear-positive TB cases detected and treated increased by 357,000 (cumulative total: 15.1 million); and the number of mosquito nets distributed rose by 59 million (cumulative total: 659 million).
3. NEWS: Another 18 grants okayed for funding
In July 2016, the Global Fund approved $364 million in funding for 18 country grants, of which $152 million represented new money. Haiti and Madagascar received the largest awards.
4. NEWS and ANALYSIS: Tracking Global Fund investments in human rights programs
Funding human rights programs remains a significant challenge for the Global Fund, particularly for TB and malaria. This article explains how and where the Fund is investing in human rights.
5. ANALYSIS: Overview of activities in the EECA related to transition planning
There is considerable work being done on transition planning in Eastern Europe and Central Asia. This article provides a summary.
6. NEWS: The OIG’s latest audit of grants to Zimbabwe shows mixed results
An audit on grants to Zimbabwe by the Office of the Inspector General yields mixed results. Internal controls and grant implementation arrangements were judged to be effective. However, the OIG said improvements were needed in the quality of the services and in supply chain management.
7. NEWS: The Global Fund at the AIDS 2016 conference
There were many sessions on topics related to the Global Fund at the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa. This article provides an overview.
8. NEWS: Donor funding for HIV declines for the first time in five years: report
A report from the Kaiser Foundation and UNAIDS says that funding for HIV declined in 13 of 14 low- and middle-income countries assessed.
9. NEWS: OIG investigation into a South Sudan SR uncovers more than $0.5 million in non-compliant expenditures
Prompted by findings from an audit of grants to South Sudan conducted in 2015, the Office of the Inspector General undertook an investigation which identified more than $500,000 in non-compliant expenditures by a sub-recipient.
10. NEWS: CSOs call on the U.N. to appoint Independent Expert on human rights violations related to SOGI
More than 600 NGOs from 151 countries signed a Joint Civil Society Statement calling on the U.N. Human Rights Council to appoint an Independent Expert to address human rights violations based on sexual orientation and gender identity.
This is issue 292 of the GLOBAL FUND OBSERVER (GFO) Newsletter.
Please send all suggestions for news items, commentaries or any other feedback
to David Garmaise, GFO Editor (firstname.lastname@example.org).
To subscribe to GFO, go to www.aidspan.org.
GFO Newsletter is a free and independent source of news, analysis and commentary
about the Global Fund to Fight AIDS, TB and Malaria (www.theglobalfund.org).
Aidspan (www.aidspan.org) is a Kenya-based international NGO that serves as an
independent watchdog of the Global Fund, aiming to benefit all countries wishing
to obtain and make effective use of Global Fund resources.
Aidspan finances its work through grants from foundations and bilateral donors.
Aidspan does not accept Global Fund money, perform paid consulting work, or
charge for any of its products.
GFO Newsletter is now available in English and French. Articles are also available in Russian.
Reproduction of articles in the newsletter is permitted if the following is stated: "Reproduced from the Global Fund Observer Newsletter, a service of Aidspan."
Click here to unsubscribe.
GFO archives are available here.
Copyright (c) 2016 Aidspan. All rights reserved.